کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6486761 | 1222 | 2012 | 13 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Development of health biotechnology in developing countries: Can private-sector players be the prime movers?
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
PDPsS&TSmall to medium enterpriseUNDPAPECproduct development partnershipsFDAPCTMMVPNIMVIHDIGERDOECDSMEWIPOPatent Cooperation TreatyIDCIPMPIDPPPNiS - NISMillennium Development Goals - اهداف توسعه هزارهUnited States of America - ایالات متحده آمریکاUSA - ایالات متّحدهٔ آمریکاAIDS - ایدزUnited Nations Development Program - برنامه توسعه سازمان ملل متحدNational Immunization Program - برنامه ملی ایمن سازیResearch and development - تحقیق و توسعهR&D - تحقیق و توسعهGross domestic product - تولید ناخالص داخلیGDP - تولید ناخالص ملیEconomic growth - رشد اقتصادیWorld Health Organization - سازمان بهداشت جهانیWTO - سازمان تجارت جهانیWorld Trade Organization - سازمان تجارت جهانیOrganization for Economic Co-operation and Development - سازمان همکاری و توسعه اقتصادیTrips - سفرهاacquired immune deficiency syndrome - سندروم نقص ایمنی اکتسابیNational innovation system - سیستم نوآوری ملیHuman Development Index - شاخص توسعه انسانیInternational Monetary Fund - صندوق بین المللی پولIMF - صندوق بین المللی پولUnited Nations Children's Fund - صندوق کودکان سازمان ملل متحدScience and technology - علم و تکنولوژیPublic private partnership - مشارکت خصوصی دولتیPublic/private partnership - مشارکت دولتی / خصوصیhuman immunodeficiency virus - ویروس نقص ایمنی انسانیHIV - ویروس نقص ایمنی انسانی WHO - کهUNICEF - یونیسف
موضوعات مرتبط
مهندسی و علوم پایه
مهندسی شیمی
بیو مهندسی (مهندسی زیستی)
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biotechnology Advances - Volume 30, Issue 6, NovemberâDecember 2012, Pages 1589-1601
Journal: Biotechnology Advances - Volume 30, Issue 6, NovemberâDecember 2012, Pages 1589-1601
نویسندگان
Gulifeiya Abuduxike, Syed Mohamed Aljunid,